Sign in
4

Changes in Ownership

Alzamend Neuro, Inc. Filed Acc 0001214659-26-009596

Options or other derivatives

  • Director acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hyperscale Data, Inc. · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-31 Grant or award : show line 1 in the form Series D Convertible Preferred Stock +7,500 $1,000.00 $7,500,000 7,500 I
Loading xslF345X06/marketforms-73681.xml…